Skip to main content

Table 2C GHRP-2 loading test on the fifth day after admission

From: Pembrolizumab-induced secondary adrenal insufficiency due to adrenocorticotrophic hormone deficiency in a patient with non-small-cell lung carcinoma: a case report

   

Time (min)

Reference Range*

Basal

15

30

45

60

GH

ng/mL

(< 2.47)

0.62

35.9

34.4

28.5

19.9

  1. Pralmorelin hydrochloride (100 µg) was injected intravenously. GH: growth hormone; GHRP-2: Growth hormone-releasing peptide-2
  2. *Basal levels
Back to article page

Journal of Pharmaceutical Health Care and Sciences

ISSN: 2055-0294

Contact us